UiPath (PATH) Panoramica del titolo
UiPath, Inc. fornisce una piattaforma di automazione che offre una gamma di soluzioni di automazione robotica dei processi (RPA) principalmente negli Stati Uniti, in Romania, nel Regno Unito, nei Paesi Bassi e a livello internazionale. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 5/6 |
| Crescita futura | 1/6 |
| Prestazioni passate | 5/6 |
| Salute finanziaria | 6/6 |
| Dividendi | 0/6 |
Premi
Analisi del rischio
Non sono stati rilevati rischi per PATH dai nostri controlli di rischio.
PATH Community Fair Values
Create NarrativeSee what 424 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
UiPath
37.0% sottovalutato sconto intrinseco
One of the first real AI-native winners
View narrativeQU
Updated 28 Aug
Concorrenti di UiPath, Inc.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$13.57 |
| Massimo di 52 settimane | US$19.84 |
| Minimo di 52 settimane | US$9.20 |
| Beta | 1.02 |
| Variazione di 1 mese | -12.96% |
| Variazione a 3 mesi | 27.42% |
| Variazione di 1 anno | 16.88% |
| Variazione a 3 anni | -25.28% |
| Variazione a 5 anni | -74.66% |
| Variazione dall'IPO | -80.33% |
Notizie e aggiornamenti recenti
Aggiornamento narrativa • Sep 03
PATH: AI Orchestration And Execution Will Shape A Measured Repricing Outlook
UiPath's updated analyst price target moves higher to align with recent Street increases toward $15 to $19. This shift is supported by checks that analysts say point to a firmer revenue outlook, slightly stronger profitability and a modestly higher assumed future P/E multiple.Seeking Alpha • Aug 31
UiPath: Maybe Not That Great Ahead Of Earnings
Summary UiPath Inc. has evolved from RPA pioneer to a leader in Agentic AI, offering a comprehensive automation platform with new orchestration products like Mestro Flow. PATH faces intensifying competition from Microsoft, OpenAI, and other large AI players, with its moat real but increasingly contested and volatility tied to competitive headlines. Q1 FY2026 delivered 17% YoY revenue growth, first-ever GAAP profitable first quarter, $1.9B ARR (+12% YoY), and a net retention rate rising to 109%. Management highlights early signs of re-acceleration, with $1M+ ARR customers up 18% YoY and remaining performance obligations increasing 15% to $1.4B. Read the full article on Seeking AlphaRecent updates
Aggiornamento narrativa • Sep 03
PATH: AI Orchestration And Execution Will Shape A Measured Repricing Outlook
UiPath's updated analyst price target moves higher to align with recent Street increases toward $15 to $19. This shift is supported by checks that analysts say point to a firmer revenue outlook, slightly stronger profitability and a modestly higher assumed future P/E multiple.Seeking Alpha • Aug 31
UiPath: Maybe Not That Great Ahead Of Earnings
Summary UiPath Inc. has evolved from RPA pioneer to a leader in Agentic AI, offering a comprehensive automation platform with new orchestration products like Mestro Flow. PATH faces intensifying competition from Microsoft, OpenAI, and other large AI players, with its moat real but increasingly contested and volatility tied to competitive headlines. Q1 FY2026 delivered 17% YoY revenue growth, first-ever GAAP profitable first quarter, $1.9B ARR (+12% YoY), and a net retention rate rising to 109%. Management highlights early signs of re-acceleration, with $1M+ ARR customers up 18% YoY and remaining performance obligations increasing 15% to $1.4B. Read the full article on Seeking Alpha
Aggiornamento narrativa • Aug 28
The AI Opportunity Is Still There, but the Upside Looks More Limited
My original thesis for UiPath was that it could become one of the major beneficiaries of the second phase of the AI boom, where AI moves beyond generating answers and starts actually doing work. That thesis hasn’t disappeared.Aggiornamento narrativa • Jul 10
PATH: AI Automation And ARR Execution Will Drive Future Repricing
UiPath's analyst fair value estimate has been trimmed from $17.00 to about $16.29 as analysts adjust their price targets into a tighter $12 to $15 range. This reflects solid recent results, but also a preference to see stronger, more consistent ARR momentum and clearer AI driven benefits before becoming more positive.
Aggiornamento narrativa • Jun 26
PATH: Agentic AI Adoption Will Strengthen Future ARR Visibility Despite Cautious Sentiment
UiPath's consensus narrative has shifted slightly lower as the average analyst price target edges down by about $0.50. This reflects solid Q1 results and improved profitability assumptions, offset by more cautious expectations for revenue growth and future P/E multiples, while analysts wait for clearer evidence of faster ARR growth from AI driven deals.Articolo di analisi • Jun 17
UiPath (PATH) Stock Could Be 24% Undervalued After Maestro Case Launch
UiPath (PATH) is back in focus after launching Maestro Case, an AI-native case management capability that targets complex, exception-heavy workflows, with early adopters reporting sizable efficiency gains and projected cost savings. See our latest analysis for UiPath. Despite Maestro Case and recent customer wins such as One New Zealand Limited, short term selling pressure has left UiPath’s share price down 33.75% year to date and the 5 year total shareholder return down 84.94%. This points...Articolo di analisi • Jun 11
UiPath's (NYSE:PATH) Promising Earnings May Rest On Soft Foundations
UiPath, Inc. ( NYSE:PATH ) just reported some strong earnings, and the market reacted accordingly with a healthy uplift...
Nuova narrativa • May 18
AI Automation Demand And Margin Expansion Will Support Steady Performance Over Time
Catalysts About UiPath UiPath provides an automation and AI software platform that helps enterprises build, orchestrate and govern digital workflows. What are the underlying business or industry changes driving this perspective?Aggiornamento narrativa • May 02
PATH: Agentic AI Automation Adoption Will Drive Future ARR Stability
Analysts have trimmed their average price targets on UiPath by several dollars, bringing them into a roughly $12 to $17 range. They cited strong Q4 execution and growing AI driven automation use cases, along with valuation compression across software peers and a need for clearer evidence of sustained AI monetization and net new ARR growth.Aggiornamento narrativa • Apr 18
PATH: Agentic AI Automation And ARR Stability Will Drive Future Upside
Analysts have reduced UiPath's average price target by a few dollars to a roughly mid-teens dollar value. They cite solid Q4 execution and ARR trends, but also point to valuation compression across software peers, along with a need for clearer AI monetization and sustained net new ARR growth.Aggiornamento narrativa • Apr 03
PATH: Agentic AI Automation And ARR Stability Will Support Future Upside
Analysts have nudged the average price target for UiPath slightly lower to around the mid teens in $ terms, trimming expectations on valuation multiples, even as they cite solid Q4 execution, steady ARR trends and growing interest in AI driven automation as key supports for the story. Analyst Commentary Recent research points to a mixed but generally balanced view on UiPath, with most firms trimming price targets while acknowledging solid Q4 execution, resilient ARR and growing interest in AI driven automation.Aggiornamento narrativa • Mar 20
PATH: Agentic AI Automation And Healthcare Solutions Will Support Future Upside
UiPath's updated analyst fair value estimate has shifted from $15.93 to $13.81 as analysts reset price targets across the $12 to $18 range, weighing solid Q4 execution, AI driven automation traction and improving margins against valuation compression, flat to stabilizing net new ARR, and the need for clearer proof of sustained AI monetization. Analyst Commentary Recent research points to a split view on UiPath, with most firms reducing price targets but highlighting both encouraging execution in Q4 and unresolved questions around future growth and valuation.Nuova narrativa • Mar 12
AI Automation Platform Will Benefit From Long Term Cross System Workflow Complexity
Catalysts About UiPath UiPath provides an end to end automation and AI platform that helps enterprises automate complex workflows across systems, people and software. What are the underlying business or industry changes driving this perspective?Aggiornamento narrativa • Mar 06
PATH: Healthcare AI Launch And Index Additions Will Support Future Upside
Analysts have trimmed their blended price target for UiPath by about $0.27 to reflect a slightly lower fair value estimate of $15.93, modestly higher discount rate assumptions, and only small tweaks to long term margin and P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts see scope for UiPath to reach a price target of US$18, which sits above the trimmed blended fair value estimate of US$15.93, suggesting room for upside if execution aligns with their assumptions.Aggiornamento narrativa • Feb 19
PATH: Index Additions And Buybacks Will Support Future Automation Upside
Analysts have trimmed their UiPath fair value estimate slightly to $16.19 from $16.40, citing mixed expectations around future profitability and valuation multiples, even as revenue assumptions stay relatively steady. Analyst Commentary Street research on UiPath reflects a mix of optimism around sector conditions and caution around how that translates into the company’s valuation and execution over time.Articolo di analisi • Feb 06
Some Confidence Is Lacking In UiPath, Inc. (NYSE:PATH) As Shares Slide 30%
UiPath, Inc. ( NYSE:PATH ) shares have had a horrible month, losing 30% after a relatively good period beforehand. The...Aggiornamento narrativa • Feb 05
PATH: AI Software Setup And Index Adds Will Support Automation Outlook
Narrative Update on UiPath UiPath’s implied analyst price target has ticked higher as recent research cites a move from $16 to $18 at one firm and from $12 to $14 at another, with analysts pointing to a generally supportive backdrop for software and ongoing interest in AI related opportunities as key drivers for the updated views. Analyst Commentary Recent research on UiPath centers on how the shares might reflect a mixed backdrop for software, AI related themes, and current valuation levels.Aggiornamento narrativa • Jan 21
PATH: AI Software Setup And Index Adds Will Support Automation Outlook
Narrative update Analysts have nudged their fair value view for UiPath slightly higher, reflecting price target moves such as Barclays lifting its target to US$18 from US$16 and RBC Capital moving to US$14 from US$12, citing a more constructive setup for software and AI exposed names. Analyst Commentary Recent research is broadly constructive, but it also highlights that expectations around AI and software can still be a source of swings in sentiment for UiPath.Aggiornamento narrativa • Jan 07
PATH: AI Trade Enthusiasm And Index Adds Will Shape Automation Outlook
Analysts have inched their fair value estimate for UiPath lower from $16.40 to about $16.27 per share, while still lifting some price targets, such as the move to $14 at RBC Capital. This reflects mixed views as they weigh AI related enthusiasm against updated assumptions for growth, margins and future P/E multiples.Articolo di analisi • Dec 23
UiPath Inc.'s (NYSE:PATH) 28% Price Boost Is Out Of Tune With Revenues
The UiPath Inc. ( NYSE:PATH ) share price has done very well over the last month, posting an excellent gain of 28%. The...Aggiornamento narrativa • Dec 21
PATH: AI Partnerships Will Support Automation Gains While Competition Keeps Outlook Balanced
Analysts have modestly increased their fair value estimate for UiPath from approximately $15.93 to $16.40 per share, reflecting a slightly higher long term growth outlook supported by recent price target raises tied to AI driven product enhancements and partnerships, despite ongoing competitive pressures. Analyst Commentary Recent Street commentary reflects a cautiously constructive stance on UiPath, with modest target price increases framed by both optimism around AI driven automation and recognition of intense competitive dynamics.Aggiornamento narrativa • Dec 07
PATH: AI Partnerships Will Drive Automation Hype Yet Leave Shares Vulnerable
UiPath's updated fair value estimate has risen to approximately $15.93 from $13.86, as analysts modestly lift price targets in response to new product launches, strategic partnerships, and expectations that the company can increasingly leverage AI trends, despite a still competitive market. Analyst Commentary Analysts remain measured on UiPath, modestly increasing price targets while keeping neutral ratings as they weigh improving product momentum against a still challenging competitive backdrop.Aggiornamento narrativa • Nov 23
PATH: Partnerships And New AI Offerings Will Shape Automation Leadership Ahead
Analysts have modestly increased their price target for UiPath, raising it from approximately $13.71 to $13.86 per share. They cite recent product updates and ongoing developments in the AI and automation space as supportive factors for the adjustment.Aggiornamento narrativa • Nov 08
PATH: Product Partnerships And Updates Will Shape Future Opportunities In Automation
UiPath's analyst price target has increased to $13 from $12.50, as analysts recognize ongoing product updates and partnerships but remain cautious about the company's growth prospects in a competitive market. Analyst Commentary Recent analyst updates reflect a nuanced perspective on UiPath's future, highlighting both supportive and cautious sentiments about the company's execution and long-term growth prospects.Aggiornamento narrativa • Oct 25
Expanding Automation Partnerships And AI-Powered Agents Will Drive Business Momentum
UiPath’s analyst price target has been revised upward to $13 from $12.50, as analysts cite ongoing product innovation and new partnerships. This comes despite expectations of gradual top-line impact amid ongoing market competition.Aggiornamento narrativa • Oct 10
Agent Builder And Agentic Orchestration Will Expand Market Opportunities
UiPath’s analyst price target has been modestly increased from $13.30 to $13.44, as analysts cite ongoing product and partnership developments. However, they also note persistent competitive pressures in the automation market.Articolo di analisi • Oct 07
What UiPath Inc.'s (NYSE:PATH) 26% Share Price Gain Is Not Telling You
UiPath Inc. ( NYSE:PATH ) shareholders would be excited to see that the share price has had a great month, posting a...Aggiornamento narrativa • Sep 06
Agent Builder And Agentic Orchestration Will Expand Market Opportunities
UiPath’s price target has been revised down due to a sharp year-over-year decline in net new ARR and heightened long-term market uncertainty, reflecting a lowered fair value from $14.15 to $13.30. Analyst Commentary Net new annual recurring revenue rose by $30M, but this represents a 30% year-over-year decline.Rendimenti per gli azionisti
| PATH | US Software | US Mercato | |
|---|---|---|---|
| 7D | -24.6% | -0.7% | -0.2% |
| 1Y | 16.9% | -9.0% | 14.8% |
Ritorno vs Industria: PATH ha superato il US Software che ha restituito -9 % nell'ultimo anno.
Rendimento vs Mercato: PATH ha superato il mercato US che ha restituito 14.8 % nell'ultimo anno.
Volatilità dei prezzi
| PATH volatility | |
|---|---|
| PATH Average Weekly Movement | 9.6% |
| Software Industry Average Movement | 9.2% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Prezzo delle azioni stabile: PATH non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato US.
Volatilità nel tempo: La volatilità settimanale ( 10% ) di PATH è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 2005 | 3,981 | Daniel Dines | www.uipath.com |
UiPath, Inc. fornisce una piattaforma di automazione che offre una gamma di soluzioni di automazione dei processi robotici (RPA) principalmente negli Stati Uniti, in Romania, nel Regno Unito, nei Paesi Bassi e a livello internazionale. Offre la piattaforma UiPath, una piattaforma software aziendale integrata che consente ad agenti AI, robot, persone e modelli di lavorare insieme in flussi di lavoro coordinati. La piattaforma UiPath dell'azienda comprende l'orchestrazione dei processi e l'intelligenza dei processi UiPath Maestro; il costruttore di agenti UiPath; l'automazione RPA e API; l'estrazione e l'elaborazione intelligente UiPath; il cloud di test UiPath per il collaudo e l'assicurazione della qualità; le soluzioni agenziali preconfezionate e predefinite UiPath e le funzionalità di governance centralizzate che si applicano alle automazioni, agli agenti AI e alle attività manuali.
UiPath, Inc. Riepilogo dei fondamenti
| PATH statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$7.30b |
| Utili (TTM) | US$361.92m |
| Ricavi(TTM) | US$1.72b |
19.5x
Rapporto P/E4.1x
Rapporto P/SPATH è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| PATH Conto economico (TTM) | |
|---|---|
| Ricavi | US$1.72b |
| Costo del fatturato | US$299.72m |
| Profitto lordo | US$1.42b |
| Altre spese | US$1.06b |
| Utili | US$361.92m |
Ultimi utili riportati
Jul 31, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | 0.69 |
| Margine lordo | 82.58% |
| Margine di profitto netto | 21.03% |
| Rapporto debito/patrimonio netto | 0% |
Come si è comportato PATH nel lungo periodo?
Vedi performance storica e confrontoAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/09/09 19:34 |
| Prezzo dell'azione a fine giornata | 2026/09/09 00:00 |
| Utili | 2026/07/31 |
| Utili annuali | 2026/01/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
UiPath, Inc. è coperta da 31 analisti. 21 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Raimo Lenschow | Barclays |
| William Kingsley Crane | Berenberg |
| Keith Bachman | BMO Capital Markets Equity Research |